Table 3.
Treatment | Sugar (mg g−1 DW) | Protein (mg g−1 FW) | Nitrate reductase activity (µmol NO2 g−1 FW h−1) | Proline (µg g−1 DW) |
---|---|---|---|---|
Control | 3.62 ± 0.12b | 21.24 ± 0.76a | 22.69 ± 0.54a | 20.51 ± 0.63c |
SPD | 4.19 ± 0.48a | 23.14 ± 0.67a | 24.86 ± 0.93a | 18.54 ± 0.54d |
CA1 | 2.81 ± 0.18c | 19.41 ± 0.46b | 19.68 ± 0.98c | 25.85 ± 1.31b |
SPD + CA1 | 3.05 ± 0.15b | 20.19 ± 0.83b | 21.36 ± 0.96b | 26.33 ± 0.41b |
CA2 | 2.46 ± 0.22c | 16.34 ± 0.78c | 17.94 ± 0.99d | 28.92 ± 0.92a |
SPD + CA2 | 2.93 ± 0.54c | 18.54 ± 0.52b | 20.22 ± 0.57b | 29.13 ± 0.18a |
Data are expressed as mean ± standard error of three independent experiments with three replicates. The values followed by different letters indicate a significant difference between treatments according to ANOVA and DMRT.